Wellframe, a Boston-based company that combines mobile technology and artificial intelligence to amplify caring clinical relationships by engaging patients in personalized care plans, announced that it has closed on $8.5 million in financing. DFJ led the round with participation from Formation 8, Waterline Ventures and Queensbridge Venture Partners.

The new financing will support expansion of engineering team to accelerate product development in response to growing market demand.

The company secured a $1.5 seed round earlier in 2014 with investments from leading entrepreneurs and investors, including Athenahealth CEO Jonathan Bush and DFJ founder Tim Draper. Since that time, Wellframe has extensively grown its team and expanded the breadth of care plans offered through its mobile platform, which now supports mental health, diabetes, transplant medicine and more.

Wellframe focuses on enabling healthcare stakeholders to amplify and extend caring relationships.“We don’t believe that technology is a replacement for human care,” said Jacob Sattelmair, Wellframe CEO and co-founder. “Instead, we’re bringing together world-class engineers, data scientists and clinicians to deliver a solution that enables our partners to provide a more effective and scalable service that optimizes patient adherence to holistic care plans.”

Wellframe focuses on enabling healthcare stakeholders to amplify and extend caring relationships through the use of mobile technologies, artificial intelligence and machine learning to maximize patient engagement. It has completed several successful clinical trials with top-tier academic medical centers and plans to announce a number of commercial partnerships in the coming months.